Login / Signup

Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Juste Aristide GoungoungaRoch Giorgi
Published in: Journal of cancer research and clinical oncology (2018)
Keyphrases
  • clinical trial
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • randomized controlled trial
  • free survival
  • patient reported